Job listing for Geisinger Health System — smokers need not apply
DANVILLE, Pa. — Geisinger Health System may be the largest employer to discriminate against a declining minority — smokers — beginning Feb. 1.
Geisinger last week announced it will no longer hire job applicants who use tobacco products, including cigarettes, cigars and chewing or smokeless tobacco.
“Geisinger is joining dozens of hospitals and medical organizations across the country that are encouraging healthier living, decreasing absenteeism and reducing healthcare costs by adopting strict policies that make smoking a reason to turn away job applicants,” stated Richard Merkle, chief human resources officer at Geisinger Health System. “Non-nicotine hiring policies are legal in 20 states, including Pennsylvania.”
This policy also affects any applicants receiving offer letters as of Feb. 1. During the hiring process, all applicants — including those seeking full- and part-time positions, flex, volunteers and students enrolled in Geisinger-based schools — will be tested for nicotine as part of the routine drug screening.
The test will include screening for cigarettes, smokeless tobacco, snuff, nicotine patches, nicotine gum and cigars. The test only detects active nicotine users, not those exposed to second-hand smoke.
“Applicants who test positive for nicotine use will be welcome to re-apply in six months provided they are nicotine-free at that time,” Merkle said. “A listing of smoking cessation resources will be provided to any applicant who tests positive for nicotine.”
Current employees are not affected by this new policy but are encouraged to take advantage of the tobacco cessation programs offered through Geisinger’s Employee Wellness program.
Geisinger currently has a no-tobacco-use policy that extends across all of its properties.
Actavis begins shipping generic Clobex shampoo, topical lotion
MORRISTOWN, N.J. — Actavis has begun shipping clobetasol propionate shampoo and clobetasol propionate lotion, which were granted 180-day marketing exclusivity by the Food and Drug Administration.
The shampoo and topical lotion are generic equivalents of Galderma’s Clobex shampoo and Clobex topical lotion, which have garnered sales of $89.9 million for the 12 months ended in September 2011.
"The launch of clobetasol propionate shampoo and clobetasol propionate lotion displays our continuing commitment to introduce new, high quality generic products to the marketplace, as well as highlights our expertise in developing and manufacturing a wide range of dosage forms," Actavis CEO Doug Boothe said. "Actavis’ drive to be a leader in generic pharmaceuticals is supported by one of the largest product development pipelines in the industry."
Mead Johnson retests Enfamil batch and affirms no contamination
GLENVIEW, Ill. — Mead Johnson Nutrition over the holidays conducted a new round of testing on samples of a batch of Enfamil Premium Newborn powdered formula related to a Food and Drug Administration investigation.
Drawn from samples parallel to those being tested by public health officials and following the same methodology, the new testing did not detect any presence of Cronobacter (Enterobacter sakazakii), the company stated.
These new results reaffirm the testing conducted before the batch was made available to retailers and consumers. "Based on both sets of tests, Mead Johnson can say with confidence that Enfamil Premium Newborn formula, like every infant formula the company produces, is safe," the company said. "All Mead Johnson infant formulas undergo more than 2,300 quality tests and checks to ensure that they meet or exceed all standards set by regulatory bodies, including the World Health Organization and the U.S. FDA."
The company undertook the retesting due to confusion in the marketplace — both Supervalu and Walmart removed that product from their shelves following news reports of an infant’s death. That infant had been fed the Enfamil product, however there has been no connection made between that product and the infant’s death.
"Our company recently became aware of an infant’s death in Missouri. This infant tested positive for Cronobacter, which is a microorganism commonly found in the environment and sometimes implicated in rare but serious illnesses in newborn babies. We were informed that the infant had been fed one of our products," Mead Johnson stated following those news reports.